Duloxetine
Product Images NDC 43353-960

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 43353-960). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Graphic- 60mg 30s (43353 0025 30)

Duloxetine HCI DR USP is a medication available in 60mg dosage form of 30 capsules. Information on Dioeine FC DR USPSmg. 30 Copsies is not-available.*

FDA Label Image

Label Graphic- 20mg 3600s (43353 0106 83)

This is a bottle of 3600 capsules containing 20mg of Duloxetine HCI DR USP. The product carries the National Occupational Classification number 3353010680.*

FDA Label Image

Label Graphic- 30mg 30s (43353 0960 30)

This text is a product label that describes a medicine called "Duloxetine HCI DR USP" which comes in a package of thirty capsules with 30mg strength. It also includes a unique identification number "NOC# 4353098030".*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Figure 1 (Duloxetine 02)

FDA Label Image

Figure 2 (Duloxetine 03)

FDA Label Image

Figure 3 (Duloxetine 04)

The text describes a chart showing the percentage of patients who have improved from their pain baseline when taking CYM60/120 mg once daily compared to a placebo. The chart indicates that 100% of patients improved when taking the medication, while no patients improved with the placebo. It also includes a graph displaying the percentage improvement in pain from the baseline.*

FDA Label Image

Figure 4 (Duloxetine 05)

This text describes a graph showing the percentage of patients who improved when taking a medication compared to a placebo. The medication is likely called CYMBO and is taken once daily. The graph also shows the percentage of improvement in pain from baseline.*

FDA Label Image

Figure 5 (Duloxetine 06)

This document appears to be a graph displaying the percentage of patients improved on placebo versus CYMB0/120 mg once daily, with a percentage range from 0 to 100. Additionally, there is another graph displaying the percentage improvement in pain from baseline using BOCF.*

FDA Label Image

Chemical Structure (Image 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.